Anti-BCMA and CD19 CART cells will be injected intravenously on a one-time basis Clinical Trials
2 recruitingDrug
Not Applicable2
Showing 1–2 of 2 trials
Recruiting
Not Applicable
CAR-T Cells Therapy for Patients With Autoimmune Diseases
Autoimmune Diseases
Anhui Provincial Hospital18 enrolled1 locationNCT07052565
Recruiting
Not Applicable
Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma
Lymphoblastic LeukemiaRelapsed or Refractory Multiple Myeloma (RRMM)
Anhui Provincial Hospital18 enrolled1 locationNCT06961669